US: 1.646.568.9797 (24x5)
UK: 44.330.808.0580 (24x5)
Worldwide: 91.703.051.960 (24x7)
"The ongoing Coronavirus (COVID-19) pandemic is re-shaping everything from global economies to product categories, pricing, and stock availability to the consumer behavior. The final report is updated to address the impact of COVID-19 on the Human Growth Hormone Drugs market. Trusted Business Insights is tracking mining/oil and gas, transportation, employment services, travel arrangements, and the leisure and hospitality sector closely as they are likely to be the hardest-hit sectors. Utilities, local pharma, diagnostics, consumer goods and durables, agro chem and fertilizers, and telecommunications are the sectors that will be weathering the COVID-19 storm and most likely come out relatively unscathed. Interdependencies of sectors are factored in our research report on the Human Growth Hormone Drugs market." HGH, produced by the pituitary gland, spurs growth in children and adolescents. It also helps to regulate body composition, body fluids, muscle and bone growth, sugar and fat metabolism, and possibly heart function. Produced synthetically, HGH is the active ingredient in a number of prescription drugs and in other products available widely over the Internet. Human growth hormone is a peptide hormone, stimulating growth in children and adolescents, and is produced by the pituitary gland. It helps in the growth of bones and muscles by specific cellular differentiation. Apart from stimulating growth, the human growth hormone also regulates carbohydrate metabolism, protein metabolism and fat metabolism. Moreover, the usage of human growth hormone drugs in growth hormone deficient patient has shown significant positive results on the patients working capacity, mental alertness and memory. The over secretion of growth hormone leads to gigantism and its deficiency causes dwarfism. The human growth hormone drugs are developed and manufactured by recombinant DNA technology. Earlier, these drugs were mostly used as replacement therapy in pediatric and adult patients, having the deficiency of growth hormones. However, the technological advancements and increased research and development in growth hormone drugs, have resulted in the development of anti-aging drugs and performance enhancers. The global Human Growth Hormone Drugs market is valued at 37000 million US$ in 2018 is expected to reach 66500 million US$ by the end of 2025, growing at a CAGR of 7.6% during 2019-2025. This report focuses on Human Growth Hormone Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Human Growth Hormone Drugs market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan. At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report. The following manufacturers are covered: Eli Lilly and Company (US) Ferring Holding SA (Switzerland) Genentech, Inc. (US) GeneScience Pharmaceuticals Co., Ltd. (China) Merck KgaA (Germany) Novo Nordisk A/S (Denmark) Pfizer, Inc. (US) Sandoz International GmbH (Germany) Segment by Regions North America Europe China Japan Segment by Type Norditropin Genotropin Humatrope Saizen Omnitrope Somatropin Biopartners Segment by Application Prader-Willi Syndrome Turner Syndrome Short Stature Homeobox Gene Small for Gestational Age Chronic Renal Insufficiency Short Bowel Syndrome
Table of Contents Executive Summary 1 Human Growth Hormone Drugs Market Overview 1.1 Product Overview and Scope of Human Growth Hormone Drugs 1.2 Human Growth Hormone Drugs Segment by Type 1.2.1 Global Human Growth Hormone Drugs Production Growth Rate Comparison by Type (2014-2025) 1.2.2 Norditropin 1.2.3 Genotropin 1.2.4 Humatrope 1.2.5 Saizen 1.2.6 Omnitrope 1.2.7 Somatropin Biopartners 1.3 Human Growth Hormone Drugs Segment by Application 1.3.1 Human Growth Hormone Drugs Consumption Comparison by Application (2014-2025) 1.3.2 Prader-Willi Syndrome 1.3.3 Turner Syndrome 1.3.4 Short Stature Homeobox Gene 1.3.5 Small for Gestational Age 1.3.6 Chronic Renal Insufficiency 1.3.7 Short Bowel Syndrome 1.4 Global Human Growth Hormone Drugs Market by Region 1.4.1 Global Human Growth Hormone Drugs Market Size Region 1.4.2 North America Status and Prospect (2014-2025) 1.4.3 Europe Status and Prospect (2014-2025) 1.4.4 China Status and Prospect (2014-2025) 1.4.5 Japan Status and Prospect (2014-2025) 1.5 Global Human Growth Hormone Drugs Market Size 1.5.1 Global Human Growth Hormone Drugs Revenue (2014-2025) 1.5.2 Global Human Growth Hormone Drugs Production (2014-2025) 2 Global Human Growth Hormone Drugs Market Competition by Manufacturers 2.1 Global Human Growth Hormone Drugs Production Market Share by Manufacturers (2014-2019) 2.2 Global Human Growth Hormone Drugs Revenue Share by Manufacturers (2014-2019) 2.3 Global Human Growth Hormone Drugs Average Price by Manufacturers (2014-2019) 2.4 Manufacturers Human Growth Hormone Drugs Production Sites, Area Served, Product Types 2.5 Human Growth Hormone Drugs Market Competitive Situation and Trends 2.5.1 Human Growth Hormone Drugs Market Concentration Rate 2.5.2 Human Growth Hormone Drugs Market Share of Top 3 and Top 5 Manufacturers 2.5.3 Mergers ... | read more...